Bactericidal and morphological effects of NE-2001, a novel synthetic agent directed against Helicobacter pylori

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 8, 2005, Pages 3468-3473

  Dai, Guofei ^b   Cheng, Ni ^a   Dong, Lei ^a   Muramatsu, Mutsumi ^a   Xiao, Shudong ^c   Wang, Ming Wei ^b,d,e   Zhu, De Xu ^a  

^a NANJING UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d Shanghai East Best Biopharmaceutical Enterprises Co Ltd   (China)

^e National Center for Drug Screening   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; FURAZOLIDONE; METRONIDAZOLE; NE 2001; UNCLASSIFIED DRUG;

ADULT; AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BACTERIUM ISOLATE; CELL STRUCTURE; CELL SWELLING; CELL VACUOLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; DRUG EFFECT; DRUG SYNTHESIS; GROWTH INHIBITION; HELICOBACTER PYLORI; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PH; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

ADULT; ANTI-BACTERIAL AGENTS; BIPHENYL COMPOUNDS; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; GUANIDINE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; UREASE;

EID: 23044489249     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.8.3468-3473.2005     Document Type: Article

References (24)

1. Bina, J. E., R. A. Alm, M. Uria-Nickelsen, S. R. Thomas, T. J. Trust, and R. E. W. Hancock. 2000. Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitro. Antimicrob. Agents Chemother. 44:248-254.
2. Björkholm, B., M. Sjölund, P. G. Falk, O. G. Berg, L. Engstrand, and D. I. Andersson. 2001. Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori. Proc. Natl. Acad. Sci. USA 98:14607-14612.
3. Blaser, M. 1997. Ecology of Helicobacter pylori in the human stomach. J. Clin. Investig. 100:759-762.
4. Cheng, N., J. S. Xie, M. Y. Zhang, C. Shu, and D. X. Zhu. 2003. A specific anti-Helicobacter pylori agent NE2001: synthesis and its effect on the growth of H. pylori. Bioorg. Med. Chem. Lett. 13:2703-2707.
5. Dunn, B. E., H. Cohen, and M. J. Blaser. 1997. Helicobacter pylori. Clin. Microbiol. Rev. 10:720-741.
6. Forman, D., D. G. Newell, F. Fullerton, J. W. Yarnell, A. R. Stacey, N. Wald, and F. Sitas. 1991. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br. Med. J. 302:302-305.
7. Genta, R. M., I. E. Gurer, and D. Y. Graham. 1995. Geographical pathology of Helicobacter pylori infection: is there more than one gastritis? Ann. Med. 27:595-599.
8. Gisbert, J. P., and J. M. Pajares. 2001. Helicobacter pylori therapy: first-line options and rescue regimen. Dig. Dis. 19:134-143.
9. Jenks, P. J., and D. I. Edwards. 2002. Metronidazole resistance in Helicobacter pylori. Int. J. Antimicrob. Agents 19:1-7.
10. Keto, Y., S. Takahashi, and S. Okabe. 1999. Healing of Helicobacter pylori-induced gastric ulcers in Mongolian gerbils: combined treatment with omeprazole and clarithromycin. Dig. Dis. Sci. 44:257-265.
11. Kwon, D. H., J. J. Kim, M. Lee, Y. Yamaoka, M. Kato, M. S. Osato, F. A. El-Zaatari, and D. Y. Graham. 2000. Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori. Antimicrob. Agents Chemother. 44:3203-3205.
12. Kwon, D. H., M. Lee, J. J. Kim, J. G. Kim, F. A. K. El-Zaatari, M. S. Osato, and D. Y. Graham. 2001. Furazolidone- and nitrofurantoin-resistant Helicobacter pylori: prevalence and role of genes involved in metronidazole resistance. Antimicrob. Agents Chemother. 45:306-308.
13. Liang, X., W. Z. Liu, H. Lu, W. W. Xu, and S. D. Xiao. 2003. Helicobacter pylori: in vitro induction of resistance to antibiotics and surveillances of its resistance prevalence. Chin. J. Dig. 23:146-149.
14. Malfertheiner, P., F. Megraud, C. O'Morain, A. P. Hungin, R. Jones, A. Axon, D. Y. Graham, G. Tytgat, and European Helicobacter Pylori Study Group (EHPSG). 2002. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment. Pharmacol. Ther. 16:167-180.
15. Nagahara, N., Y. Akiyama, M. Nakao, M. Tada, M. Kitano, and Y. Ogawa. 1998. Mucoadhesive microspheres containing amoxicillin for clearance of Helicobacter pylori. Antimicrob. Agents Chemother. 42:2492-2494.
16. National Committee for Clinical Laboratory Standards. 2003. Performance standards for antimicrobial susceptibility testing and approved standard M7-A6. Informational supplement M100-S15 (2005). National Committee for Clinical Laboratory Standards, Wayne, PA.
17. O'Rourke, E. J., C. Chevalier, A. V. Pinto, J. M. Thiberge, L. Ielpi, A. Labigne, and J. P. Radicella. 2003. Pathogen DNA as target for host-generated oxidative stress: role for repair of bacterial DNA damage in Helicobacter pylori colonization. Proc. Natl. Acad. Sci. USA 100:2789-2794.
18. Osato, M. S., R. Reddy, S. G. Reddy, R. L. Penland, H. M. Malaty, and D. Y. Graham. 2001. Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Arch. Intern. Med. 161: 1217-1220.
19. Penner, J. L. 1991. Campylobacter, Helicobacter, and related spiral bacteria, p. 402-409. In A. Aslows, W. J. Hausler, K. L. Herrmann, H. D. Isenberg, and H. J. Shadomy (ed.), Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
20. Piccolomini, R., G. D. Bonaventura, G. Catamo, F. Carbone, and M. Neri. 1997. Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents. J. Clin. Microbiol. 35:1842-1846.
21. Pina, M., A. Occhialini, L. Monteiro, H.-P. Doermann, and F. Mégraud. 1998. Detection of point mutations associated with resistance of Helicobacter pylori to clarithromycin by hybridization in liquid phase. J. Clin. Microbiol. 36:3285-3290.
22. Stone, J. W., R. Wise, I. A. Donovan, and J. Gearty. 1988. Failure of ciprofloxacin to eradicate Campylobacter pylori from the stomach. J. Antimicrob. Chemother. 22:92-93.
23. Wu, H., X. D. Shi, H. T. Wang, and J. X. Liu. 2000. Resistance of Helicobacter pylori to metronidazole, tetracycline and amoxycillin. J. Antimicrob. Chemother. 46:121-123.
24. Zhu, D. X., M. Muramatsu, J. S. Xie, N. Cheng, and M.-W. Wang. May 2004. Methods and compositions for treating or preventing bacterial infection. U.S. patent 6734212B2.